CDC has issued a HAN Health Advisory on Elevated Influenza Activity: Influenza B/Victoria and A(H1N1)pdm09 Viruses are the Predominant Viruses, summarized by:
“This health advisory notifies clinicians that influenza activity remains high in the United States. Ongoing elevated activity is due to influenza B/Victoria viruses, increasing circulation of influenza A(H1N1)pdm09 viruses, and low levels of influenza B/Yamagata and influenza A(H3N2) viruses. CDC’s influenza forecasts suggest that national influenza activity will remain elevated for several more weeks. Because influenza activity is elevated and both influenza A and B virus infections can cause severe disease and death, this health advisory also serves as a reminder that early treatment with antiviral medications improves outcomes in patients with influenza. Early treatment with antiviral medications is recommended for hospitalized patients and high-risk outpatients… Clinicians should continue efforts to vaccinate patients for as long as influenza viruses are circulating, and promptly start antiviral treatment of severely ill and high-risk patients with suspected influenza without waiting for laboratory confirmation.”
The National Forum of ESRD Networks has introduced or updated several Medical Advisory Council (MAC) Toolkits. Two new Kits include the Transplant Toolkit and the Medication Conversion Toolkit. The Transitions of Care Toolkit was updated in mid-April. Find them all at http://esrdnetworks.org/resources/toolkits/mac-toolkits-1, along with the existing Home Dialysis Toolkit, Medical Directors Toolkit, QAPI Toolkit, Medication Reconciliation Toolkit, Catheter Reduction Toolkit, Vaccination Toolkit, and Assurance of Diabetes Care Coordination Toolkit.
CDC has issued a Health Alert Network Advisory on Hepatitis A Virus infections, especially among drug users and homeless persons. The HAN includes recommendations for testing, vaccination, reporting, and other healthcare facility procedures. For details see https://emergency.cdc.gov/han/han00412.asp.
CDC has issued a “HAN” Health Advisory on increased influenza A(H3N2) activity and its clinical implications. The HAN also includes a summary of influenza antiviral drug treatment recommendations, an update about approved treatment drugs and current supply, and background information for patients about influenza treatment. Find the HAN at https://emergency.cdc.gov/han/han00409.asp.